Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Nano alchemy: Ionic liquids transforming metallic particles for medicine.
Related Experiment Video
Updated: Jan 24, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Prone-to-aggregate nanoparticle for cancer-targeted drug delivery.
Manisha Choudhary1, Dnyaneshwar Kalyane2, Devendra Choudhary1
1National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, An Institute of National Importance, Government of India, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Palaj, Opp. Air Force Station, Gandhinagar-382355, Gujarat, India.
Prone-to-aggregate nanoparticles (NPs) can be engineered to aggregate at tumor sites, enhancing cancer treatment efficacy and reducing side effects. This targeted aggregation strategy is key for advanced nanomedicine in oncology.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Nanoparticles (NPs) are increasingly utilized in diverse cancer management strategies.
- Their dynamic surface properties enable tailored modifications for specific biomedical applications.
- Current research prioritizes enhancing NP efficacy through tumor site concentration.
Purpose of the Study:
- To review the aggregation approach of prone-to-aggregate NPs for selective tumor delivery.
- To explore various stimuli-responsive triggers for NP aggregation.
- To discuss the therapeutic and diagnostic applications of this aggregation strategy in cancer therapy.
Main Methods:
- Review of literature on stimuli-responsive nanoparticle aggregation.
- Analysis of aggregation triggers including pH, enzymes, redox, temperature, and external fields (magnetic, light).
- Evaluation of NP applications in drug delivery, imaging, and various cancer therapies.
Main Results:
- Prone-to-aggregate NPs can achieve targeted accumulation at tumor sites via controlled aggregation.
- Stimuli-responsive aggregation enhances NP retention and reduces off-target effects.
- This approach shows promise for improving both diagnostic and therapeutic outcomes in cancer.
Conclusions:
- The aggregation of prone-to-aggregate NPs is a viable strategy for targeted cancer therapy.
- Stimuli-responsive aggregation significantly improves NP delivery and efficacy.
- This approach holds potential for advancing nanomedicine in oncology.

